Monsanto

(via Monsanto)

Monsanto says its net income increased 22 percent in the second quarter on strong sales of its biotech seeds.

The agricultural products company boosted its full-year earnings guidance, citing its strong performance in the first two quarters.

The St. Louis company says it earned $1.48 billion, or $2.74 per share in the three months ended Feb. 13. That compares to earnings of $1.21 billion, or $2.24 per share, a year ago.

Revenue climbed 15 percent to $5.47 billion.

Genetically-modified seeds — and the technology to produce them — have been at the center of a bitter legal fight between the two companies. Dupont will pay Monsanto more than $1.5 billion in the deal. With that, the companies will drop their patent and antitrust claims against each other.

(via Flickr/mike matney)

Last week, the U.S. Supreme Court heard oral arguments in a legal battle between St. Louis-based Monsanto and a 75-year-old farmer from Indiana named Vernon Hugh Bowman.

While some Supreme Court justices have already tipped their hat signifying Monsanto will likely win the case, the issue revolves around whether Bowman violated Monsanto’s patent rights when he planted soybean seeds from a grain elevator.

(Dan Charles/NPR)

Updated on Tuesday, February 19, at 6:10 p.m. to add quote from Bowman.

The U.S. Supreme Court heard oral arguments today in a legal battle between St. Louis-based Monsanto and a 75-year-old Indiana farmer.

The case revolves around whether Vernon Hugh Bowman violated Monsanto's patent rights when he bought seeds from a grain elevator and planted them.

This week, the Supreme Court will take up a classic David-and-Goliath case. On one side, there's a 75-year-old farmer in Indiana named Vernon Hugh Bowman; on the other, the agribusiness giant Monsanto.

For years, the biotech giant Monsanto has provoked outrage among its critics for suing farmers who save and replant seeds, such as soybeans and canola, from the company's patented Roundup Ready crops.

Monsanto
St. Louis Public Radio

Monsanto says its net income nearly tripled in the agricultural products company's first quarter as sales of its biotech corn seeds expanded in Latin American countries.

The company, which is based in St. Louis, is also raising its profit guidance for the year, and shares are up 4 percent in premarket trading. Monsanto said Tuesday that it earned $339 million, or 63 cents per share, in the three months ended November 30, from $126 million, or 23 cents per share, in last year's quarter.

Why do so many people hate Monsanto?

Is it because this multinational corporation pioneered some enormously successful genetically engineered crops, including corn, soybeans and cotton?

(via Flickr/A Comment)

Monsanto is leading the fight to block a California ballot initiative that would require labeling of food with genetically modified ingredients.

(via Monsanto)

Monsanto says its fiscal third-quarter net income soared 35 percent as its seeds and traits business benefited from a mild winter that drove farmers to plant crops earlier and in large numbers.

The U.S. agricultural giant also maintained its full-year earnings forecast after boosting it last month.

The St. Louis company, which produces genetically engineered seeds and the herbicide Roundup, earned $937 million, or $1.74 per share, in the quarter ended in May. That's compared with $692 million, or $1.28 per share, a year earlier.

Pages